<DOC>
	<DOCNO>NCT02096315</DOCNO>
	<brief_summary>To test whether POL7080 effective patient exacerbation non-cystic fibrosis bronchiectasis cause Pseudomonas aeruginosa infection .</brief_summary>
	<brief_title>Safety , Efficacy PK/PD POL7080 Patients With Exacerbation Non-cystic Fibrosis Bronchiectasis .</brief_title>
	<detailed_description>- Patients recruit write informed consent . - Adverse event cod use Medical Dictionary regulatory activity ( MedDRA ) . - Descriptive statistic use safety efficacy variable .</detailed_description>
	<mesh_term>Infection</mesh_term>
	<mesh_term>Fibrosis</mesh_term>
	<mesh_term>Bronchiectasis</mesh_term>
	<mesh_term>Respiratory Tract Infections</mesh_term>
	<criteria>1 . Male female age â‰¥18 &lt; 80 year suffer exacerbation noncystic fibrosis bronchiectasis due Pseudomonas aeruginosa infection 2 . Sputum sample collect culture start treatment 1 . Female patient pregnant breast feed unwilling follow reliable method contraception 2 . Subjects suffer cystic fibrosis , active pulmonary mycobacterial infection , end stage chronic obstructive pulmonary disease long term oxygen therapy , severe uncontrolled asthma , active sarcoidosis active allergic bronchopulmonary aspergillosis 3 . Current exacerbation bronchiectasis associate lung abscess empyema 4 . Current exacerbation episode suspect document due pathogen Pseudomonas aeruginosa 5 . Patients know HIV infection CD4+ ( cluster differentiation 4 ) cell count &lt; 200/mm3 6 . Patients currently enrol , yet complete least 30 day since end another investigational device drug trial receive investigational agent</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>79 Years</maximum_age>
	<verification_date>November 2015</verification_date>
	<keyword>POL7080</keyword>
	<keyword>Pseudomonas aeruginosa</keyword>
	<keyword>Non cystic fibrosis bronchiectasis</keyword>
	<keyword>Exacerbation</keyword>
</DOC>